Ładuje się......
The dawn of hedgehog inhibitors: Vismodegib
Cancer, one of the leading causes of death worldwide is estimated to increase to approximately 13.1 million by 2030. This has amplified the research in oncology towards the exploration of novel targets. Recently there has been lots of interest regarding the hedgehog (Hh) pathway, which plays a signi...
Zapisane w:
| Główni autorzy: | , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Medknow Publications & Media Pvt Ltd
2013
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3643342/ https://ncbi.nlm.nih.gov/pubmed/23662017 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0976-500X.107628 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|